Export 29 results:
Author Title [ Type(Asc)] Year
Filters: Author is Bernstein, David I  [Clear All Filters]
Journal Article
T. R. Talbot, Stapleton, J. T., Brady, R. C., Winokur, P. L., Bernstein, D. I., Germanson, T., Yoder, S. M., Rock, M. T., Crowe, J. E., and Edwards, K. M., Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial., JAMA, vol. 292, no. 10, pp. 1205-12, 2004.
L. Patricia Stadler, Bernstein, D. I., S Callahan, T., Ferreira, J., Simone, G. A. Gorgone, Edwards, K. M., Stanberry, L. R., and Rosenthal, S. L., Seroprevalence of cytomegalovirus (CMV) and risk factors for infection in adolescent males., Clin Infect Dis, vol. 51, no. 10, pp. e76-81, 2010.
L. Patricia Stadler, Bernstein, D. I., S Callahan, T., Turley, C. B., Munoz, F. M., Ferreira, J., Acharya, M., Simone, G. A. Gorgone, Patel, S. M., Edwards, K. M., and Rosenthal, S. L., Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females., J Pediatric Infect Dis Soc, vol. 2, no. 1, pp. 7-14, 2013.
M. J. Mulligan, Bernstein, D. I., Winokur, P., Rupp, R., Anderson, E., Rouphael, N., Dickey, M., Stapleton, J. T., Edupuganti, S., Spearman, P., Ince, D., Noah, D. L., Hill, H., and Bellamy, A. R., Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial., JAMA, vol. 312, no. 14, pp. 1409-19, 2014.
F. M. Munoz, Anderson, E. J., Bernstein, D. I., Harrison, C. J., Pahud, B., Anderson, E., C Creech, B., Berry, A. A., Kotloff, K. L., Walter, E. B., Atmar, R. L., Bellamy, A. R., Chang, S., and Keitel, W. A., Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents., Vaccine, vol. 37, no. 36, pp. 5161-5170, 2019.
N. B. Halasa, Gerber, M. A., Berry, A. A., Anderson, E. L., Winokur, P., Keyserling, H., Eckard, A. Ross, Hill, H., Wolff, M. C., McNeal, M. M., Edwards, K. M., and Bernstein, D. I., Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age., J Pediatric Infect Dis Soc, vol. 4, no. 3, pp. 214-24, 2015.
F. Scaggs Huang, Bernstein, D. I., Slobod, K. S., Portner, A., Takimoto, T., Russell, C. J., Meagher, M., Jones, B. G., Sealy, R. E., Coleclough, C., Branum, K., Dickey, M., Buschle, K., McNeal, M., Makowski, M., Nakamura, A., and Hurwitz, J. L., Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults., Hum Vaccin Immunother, vol. 17, no. 2, pp. 554-559, 2021.
D. I. Bernstein, Sahly, H. M. El, Keitel, W. A., Wolff, M., Simone, G., Segawa, C., Wong, S., Shelly, D., Young, N. S., and Dempsey, W., Safety and immunogenicity of a candidate parvovirus B19 vaccine., Vaccine, vol. 29, no. 43, pp. 7357-63, 2011.
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B., Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations., J Infect Dis, vol. 206, no. 6, pp. 828-37, 2012.
R. C. Brady, Jackson, L. A., Frey, S. E., Shane, A. L., Walter, E. B., Swamy, G. K., Schlaudecker, E. P., Szefer, E., Wolff, M., McNeal, M. Malone, Bernstein, D. I., and Steinhoff, M. C., Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women., Vaccine, vol. 36, no. 31, pp. 4663-4671, 2018.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. El, Rouphael, N. Georges, Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations., Vaccine, vol. 33, no. 1, pp. 163-73, 2015.
T. C. Heineman, Schleiss, M., Bernstein, D. I., Spaete, R. R., Yan, L., Duke, G., Prichard, M., Wang, Z., Yan, Q., Sharp, M. A., Klein, N., Arvin, A. M., and Kemble, G., A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines., J Infect Dis, vol. 193, no. 10, pp. 1350-60, 2006.
D. I. Bernstein, Pasetti, M. F., Brady, R., Buskirk, A. D., Wahid, R., Dickey, M., Cohen, M., Baughman, H., El-Khorazaty, J., Maier, N., Sztein, M. B., Baqar, S., and A Bourgeois, L., A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization., Vaccine, vol. 37, no. 4, pp. 602-611, 2019.
R. L. Atmar, Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., and Mendelman, P. M., Norovirus vaccine against experimental human Norwalk Virus illness., N Engl J Med, vol. 365, no. 23, pp. 2178-87, 2011.
D. I. Bernstein, Atmar, R. L., G Lyon, M., Treanor, J. J., Chen, W. H., Jiang, X., Vinjé, J., Gregoricus, N., Frenck, R. W., Moe, C. L., Al-Ibrahim, M. S., Barrett, J., Ferreira, J., Estes, M. K., Graham, D. Y., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults., J Infect Dis, vol. 211, no. 6, pp. 870-8, 2015.
K. L. Kotloff, Shirley, D. - A. T., C Creech, B., Frey, S. E., Harrison, C. J., Staat, M., Anderson, E. J., Dulkerian, S., Thomsen, I. P., Al-Hosni, M., Pahud, B. A., Bernstein, D. I., Yi, J., Petrikin, J. E., Haberman, B., Stephens, K., Stephens, I., Oler, R. E., and Conrad, T. M., Mupirocin for Decolonization of Infants in Neonatal Intensive Care Units., Pediatrics, vol. 143, no. 1, 2019.
D. I. Bernstein, Jackson, L., Patel, S. M., Sahly, H. M. El, Spearman, P., Rouphael, N., Rudge, T. L., Hill, H., and Goll, J. B., Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults., Vaccine, vol. 32, no. 47, pp. 6284-93, 2014.
P. Winokur, Sahly, H. M. El, Mulligan, M. J., Frey, S. E., Rupp, R., Anderson, E. J., Edwards, K. M., Bernstein, D. I., Schmader, K., Jackson, L. A., Chen, W. H., Hill, H., and Bellamy, A., Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older., Vaccine, vol. S0264-410X, no. 20, pp. 31504-31508, 2021.
J. M. Schulte, Bellamy, A. R., Hook, E. W., Bernstein, D. I., Levin, M. J., Leone, P. A., Sokol-Anderson, M. L., Ewell, M. G., Wolff, P. A., Heineman, T. C., and Belshe, R. B., HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women)., South Med J, vol. 107, no. 2, pp. 79-84, 2014.
D. I. Bernstein, Bellamy, A. R., Hook, E. W., Levin, M. J., Wald, A., Ewell, M. G., Wolff, P. A., Deal, C. D., Heineman, T. C., Dubin, G., and Belshe, R. B., Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women., Clin Infect Dis, vol. 56, no. 3, pp. 344-51, 2013.
R. B. Belshe, Leone, P. A., Bernstein, D. I., Wald, A., Levin, M. J., Stapleton, J. T., Gorfinkel, I., Morrow, R. L. Ashley, Ewell, M. G., Stokes-Riner, A., Dubin, G., Heineman, T. C., Schulte, J. M., and Deal, C. D., Efficacy results of a trial of a herpes simplex vaccine., N Engl J Med, vol. 366, no. 1, pp. 34-43, 2012.
D. I. Bernstein, Edwards, K. M., Dekker, C. L., Belshe, R., Talbot, H. K. B., Graham, I. L., Noah, D. L., He, F., and Hill, H., Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults., J Infect Dis, vol. 197, no. 5, pp. 667-75, 2008.
K. V. Houser, Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., Sarwar, U., Larkin, B., Bailer, R. T., Koup, R., Paskel, M., Subbarao, K., Anderson, E., Bernstein, D. I., Creech, B., Keyserling, H., Spearman, P., Wright, P. F., Graham, B. S., and Ledgerwood, J. E., DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial., PLoS One, vol. 13, no. 11, p. e0206837, 2018.
J. E. Ledgerwood, Bellamy, A. R., Belshe, R., Bernstein, D. I., Edupuganti, S., Patel, S. M., Renehan, P., Zajdowicz, T., Schwartz, R., Koup, R., Bailer, R. T., Yamshchikov, G. V., Enama, M. E., Sarwar, U., Larkin, B., and Graham, B. S., DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial., PLoS One, vol. 10, no. 5, p. e0125914, 2015.
S. A. Ross, Pati, P., Jensen, T. L., Goll, J. B., Gelber, C. E., Singh, A., McNeal, M., Boppana, S. B., and Bernstein, D. I., Cytomegalovirus Genetic Diversity Following Primary Infection., J Infect Dis, vol. 221, no. 5, pp. 715-720, 2020.